SARS-CoV-2 Antigen Rapid Test

Providing an aid in early diagnosis of individuals who are suspected of COVID-19 by their healthcare provider and who are asymptomatic.

To contact us please click here!
Location:Home > ABOUT US > News > ACON Flowflex Got Approved for Self-testing in Multi Europea...
ACON Flowflex Got Approved for Self-testing in Multi European Countries
Date:2021-04-09 Click:

Apr. 9, 2021 – ACON, oneof the professional in-vitro diagnostic products manufacturers, announced today that its Flowflex SARS-CoV-2 Antigen Rapid Test has been approved for Self-testing use in France and Denmark! Previously, Flowflex SARS-CoV-2 Antigen Rapid Test was granted for Self-testing (Laypersons) use in Germany, Netherlands, Austria and Czech.

ACON Flowflex SARS-CoV-2 Antigen Rapid Test is a lateral flow chromatographic immunoassay for the qualitative detection the nucleocapsid protein antigen from SARS-CoV-2 in nasal, saliva and nasopharyngeal swab specimens, it has a high sensitivity and specificity. The SARS-CoV-2 Antigen Rapid Test can also tests pecimens from asymptomatic individuals.
Nasal, Saliva and Nasopharyngeal swab specimens
Results in15 minutes
Excellent performance compared to molecular methods
Room temperature storage

To fight against COVID-19 epidemic, ACON has developed a full range of COVID-19 testing products including:
• Antigen Rapid Test (Nasal, Saliva, Nasopharyngeal)
• Antibody IgG/IgM Rapid Test
• FIA Antigen Test (Fluorescence ImmunoAssay)
PCR reagent & PCR analyzer
• Nucleic Extraction Reagent & Instrument
• Neutralizing Antibody (under development)